- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Insterspec agreement with Siemens breaks down
Interspec reported this month that its radiology ultrasound R&Dand marketing agreement with Siemens is off. The Ambler, PA, cardiacultrasound supplier had been working with the large German multimodalityimaging vendor to develop a radiology
Interspec reported this month that its radiology ultrasound R&Dand marketing agreement with Siemens is off. The Ambler, PA, cardiacultrasound supplier had been working with the large German multimodalityimaging vendor to develop a radiology ultrasound scanner (SCAN10/24/90).
Siemens would have had international rights to market thescanner once it was developed. Interspec retains worldwide rightsto the technology developed cooperatively. The smaller firm plansto sell the system itself through a combination of direct salesand distribution agreements, according to Edward Ray, chairmanand CEO.
"Interspec will take advantage of this opportunity andexpand its established international distribution to market itsnew product when it becomes available," Ray said.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
